@GMT2@DickyB@Sirwes
As requested, this is the Phase 3 biomed stock I hold. CD has done a full analysis on it in this thread from the start.
Has 25 mill in cash and is currently valued at 3 mill EV.
Currently phase 3 trials are ongoing and if successful unlock a 1 billion+ TAM. This is similar to NEU and CUV early days.
As for TA its at support with decent positive divergence now developing
All IMO
Chart below FYI
Cheers
Twiggy's Invex Therapeutics | The Imminent Coin Flip, page-156
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
